VNRX VOLITIONRX LTD Capital Structure Changes 8-K Filing 2024 - Stock Offering VolitionRx Ltd entered into a securities purchase agreement for a registered direct offering, selling 9,170,000 shares at $0.55 each, raising $7 million for research and product development.Get access to all SEC 8-K filings of the VOLITIONRX LTD